Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells

FEBS Letters

Volumn 584, Issue 1, 2010, Pages 141-146

  Jang, Gun Hyuk ^a   Park, In Sook ^b   Yang, Jeong Hee ^a   Bischoff, Joyce ^c   Lee, You Mie ^a  

^a Kyungpook National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Calcineurin; Down Syndrome critical region 1; Endothelial mesenchymal transdifferentiation; Heparin binding EGF like growth factor; Nuclear factor in activated T cells c1; Valve endothelial cells; Vascular endothelial growth factor

Indexed keywords

CYCLOSPORIN A; DOWN SYNDROME CRITICAL REGION 1; GENE PRODUCT; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; AORTA VALVE; ARTICLE; CELL MIGRATION; CELL REGENERATION; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; MIGRATION INHIBITION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PULMONARY VALVE; SHEEP; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CYCLOSPORINE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NFATC TRANSCRIPTION FACTORS; PULMONARY VALVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

OVIS;

EID: 71549144413     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.11.031     Document Type: Article

References (35)

1. Johnson E.N., Lee Y.M., Sander T.L., Kaushal S., Rabkin E., Schoen J.F., and Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation in human pulmonary valve endothelial cells. J. Biol. Chem. 278 (2003) 1686-1692
2. Ferencz C., Rubin J.D., McCarter R.J., Brenner J.I., Neill C.A., Perry L.W., Hepner S.I., and Downing J.W. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am. J. Epidemiol. 121 (1985) 31-36
3. Shaw J.P., Utz P.J., Durand D.B., Toole J.J., Emmel E.A., and Crabtree G.R. Identification of a putative regulator of early T cell activation genes. Science 241 (1988) 202-205
4. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
5. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 276 (2001) 2313-2316
6. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., and Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392 (1998) 186-190
7. de la Pompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Pooter J., Wakeham A., Marengere L., Langille B.L., Crabtree G.R., and Mak T.W. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392 (1998) 182-186
8. Combs M.D., and Yutzey K.E. Vascular endothelial growth factor A and RANKL regulation of NFATc1 in heart valve development. Circ. Res. 105 (2009) 565-574
9. Ramsdell A.F., and Markwald R.R. Induction of endocardial cushion tissue in the avian heart is regulated, in part, by TGFbeta-3-mediated autocrine signaling. Dev. Biol. 188 (1997) 64-74
10. Sugi Y., Yamamura H., Okagawa H., and Markwald R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 269 (2004) 505-518
11. Somi S., Buffing A.A., Moorman A.F., and Van Den Hoff M.J. Dynamic patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart development. Anat. Rec. A: Discov. Mol. Cell. Evol. Biol. 279 (2004) 636-651
12. Ma L., Lu M.F., Schwartz R.J., and Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132 (2005) 5601-5611
13. Rivera-Feliciano J., and Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 295 (2006) 580-588
14. Paranya G., Vineberg S., Dvorin E., Kaushal S., Roth S.J., Rabkin E., Schoen F.J., and Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am. J. Pathol. 159 (2001) 1335-1343
15. Walsh E.C., and Stainier D.Y. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293 (2001) 1670-1673
16. Lee Y.M., Cope J.J., Ackermann G.E., Goishi K., Armstrong E.J., Paw B.H., and Bischoff J. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Dev. Dynam. 235 (2006) 29-37
17. Mo F.E., and Lau L.F. The matricellular protein CCN1 is essential for cardiac development. Circ. Res. 99 (2006) 961-969
18. Jackson L.F., Qiu T.H., Sunnarborg S.W., Chang A., Zhang C., Patterson C., and Lee D.C. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22 (2003) 2704-2716
19. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., Adachi S., Kitakaze M., Hashimoto K., Raab G., Nanba D., Higashiyama S., Hori M., Klagsbrun M., and Mekada E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 100 (2003) 3221-3226
20. Hurlstone A.F., Haramis A.P., Wienholds E., et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425 (2003) 633-637
21. McElhinney D.B., Krantz I.D., Bason L., et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106 (2002) 2567-2574
22. Steele I.C., Nugent A.M., Maguire S., et al. Cytokine profile in chronic cardiac failure. Eur. J. Clin. Invest. 26 (1996) 1018-1022
23. Damås J.K., Eiken H.G., Oie E., Bjerkeli V., et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc. Res. 47 (2000) 778-787
24. Gusterson R.J., Jazrawi E., Adcock I.M., and Latchman D.S. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J. Biol. Chem. 278 (2003) 6838-6847
25. Wood A.W., Schlueter P.J., and Duan C. Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos. Mol. Endocrinol. 19 (2005) 1024-1034
26. Delafontaine P., Ku L., Anwar A., and Hayzer D.J. Insulin-like growth factor 1 binding protein 3 synthesis by aortic endothelial cells is a function of cell density. Biochem. Biophys. Res. Commun. 222 (1996) 478-482
27. Aase K., Ernkvist M., Ebarasi L., Jakobsson L., et al. Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev. 21 (2007) 2055-2068
28. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolós V., et al. Notch signaling is essential for ventricular chamber development. Dev. Cell 12 (2007) 415-429
29. Armstrong E.J., and Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95 (2004) 459-470
30. Li B., Fuh G., Meng G., Xin X., Gerritsen M.E., Cunningham B., and de Vos A.M. Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization. J. Biol. Chem. 275 (2000) 29823-29828
31. Wu H., Kao S.C., Barrientos T., Baldwin S.H., et al. Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development. J. Biol. Chem. 282 (2007) 30673-30679
32. Yang J.H., Wylie-Sears J., and Bischoff J. Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. Biochem. Biophys. Res. Commun. 374 (2008) 512-516
33. Paruchuri S., Yang J.H., Aikawa E., Melero-Martin J.M., Khan Z.A., Loukogeorgakis S., Schoen F.J., and Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ. Res. 99 (2006) 861-869
34. Rodgers L.S., Lalani S., Hardy K.M., Xiang X., Broka D., Antin P.B., and Camenisch T.D. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ. Res. 99 (2006) 583-589
35. Hallaq H., Pinter E., Enciso J., McGrath J., et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 131 (2004) 5197-5209